Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

NCT00530179 ·Status: COMPLETED ·Phase: NA

The Performance of Multi-tracer Multimodality PET in Lymphoma

NCT05004961 ·Status: UNKNOWN

Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma

NCT05411250 ·Status: UNKNOWN

18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

NCT05826158 ·Status: RECRUITING ·Phase: NA

Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma

NCT04367948 ·Status: UNKNOWN ·Phase: NA

Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

NCT05054998 ·Status: COMPLETED ·Phase: PHASE4

PET Study in Patients With Non-Hodgkin Lymphoma

NCT00712556 ·Status: COMPLETED

Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas

NCT05390632 ·Status: UNKNOWN

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma

NCT01410630 ·Status: COMPLETED

Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas

NCT00554164 ·Status: COMPLETED ·Phase: PHASE3

Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.

NCT00200668 ·Status: TERMINATED ·Phase: NA

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma

NCT02931201 ·Status: UNKNOWN ·Phase: NA

Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations

NCT02858167 ·Status: COMPLETED ·Phase: NA

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

NCT02325349 ·Status: TERMINATED ·Phase: PHASE2

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

NCT06795113 ·Status: RECRUITING

Detection and Characterization of Residual Masses in Lymphomas

NCT02300402 ·Status: COMPLETED

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma

NCT03051581 ·Status: UNKNOWN ·Phase: NA

Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT

NCT05068687 ·Status: COMPLETED ·Phase: NA

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma

NCT03051542 ·Status: UNKNOWN ·Phase: NA

Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression

NCT05749289 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging

NCT00499382 ·Status: TERMINATED

Molecular Pituitary Imaging Using 18F-FET PET

NCT06584123 ·Status: RECRUITING ·Phase: NA

FDG PET/CT and Directed Metabolic Core Needle Biopsy in the Management of Lymphoma

NCT05186610 ·Status: COMPLETED

Study of the Angiogenesis by PET/CT in Patients With Lymphoma

NCT02490891 ·Status: COMPLETED ·Phase: PHASE2